On July 6, 2022, the FDA updated the Emergency Use Authorization (EUA) for the COVID-19 antiviral Paxlovid, to permit pharmacists to prescribe Paxlovid under limited circumstances. The FDA hoped to...
On July 6, 2022, the Food and Drug Administration (FDA) announced that state-licensed pharmacists are authorized to prescribe the Covid-19 anti-viral medication, Paxlovid, in limited circumstances....